LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

GLENMARK

NSEBSE
F&O
Glenmark Pharmaceuticals Limited
Healthcare· Pharmaceuticals & Biotechnology· INE935A01035· Scrip: 532296
ENहिन्दीગુજરાતીमराठी
૨,૩૭૧.૪૦
46.50 (-1.92%)
6/5/2026, 3:28:22 pm
NSE
૨,૩૭૧.૪૦
૪૬.૫૦
-૧.૯૨%
BSE
૨,૩૭૩.૭૫
૪૬.૩૦
+૦.૦૦%
1,3731,6371,9022,1662,43005-0607-0108-2810-2712-2302-2004-2905-06
૨૪૫ ટ્રેડિંગ દિવસ · 1Y સમયગાળો
આજ
ખૂલ્લ૨,૪૩૫.૦૦
ઊંચ૨,૪૪૦.૦૦
નીચ૨,૩૫૪.૯૦
અગાઉ બંધ૨,૪૧૭.૯૦
વૉલ્યુમ૧૦.૯૮L
મૂલ્ય₹૨૬૪.૮Cr
L: 2,354.90H: 2,440.00
52 સપ્તાહ
નીચ૧,૩૫૫.૪૦
ઊંચ૨,૪૭૪.૦૦
૯૧% 52 સપ્તાહ રેન્જમાં
માહિતી
અંકિત મૂલ્ય₹૧
સૂચિબદ્ધ2000-02-07
ISININE935A01035
SeriesA
BSE સ્ક્રિપ532296

મુખ્ય સૂચકો

1D
-1.92%
1W
-1.34%
1M
+12.86%
3M
+20.52%
6M
+28.14%
મૂલ્યાંકન
P/E (Qtr Ann.)૪૮.૦૮
P/Sales૫.૦૪
વૃદ્ધિ (ત્રિ.)
આવક-1.35%
PAT-1.82%
EPS-1.75%
TTM આવક
₹12214 Cr
TTM EBITDA
₹2525 Cr
TTM PAT
₹-58 Cr
TTM EPS
₹-૨.૨૨

ત્રિમાસિક નાણાકીય

આવક
EBITDA
PAT
EPS
0 Cr866 Cr1732 Cr2598 Cr3464 Cr22-1223-0323-0923-1224-0324-0624-0924-129.7-15.2-2.9-12.4-43.216.112.612.3
ત્રિમાસઆવકExpensesEBITDAPBTPATEPS
2024-12-313388 Cr2962 Cr579 Cr456 Cr348 Cr12.33
2024-09-303434 Cr3001 Cr593 Cr473 Cr354 Cr12.55
2024-06-302330 Cr1767 Cr671 Cr618 Cr454 Cr16.08
2024-03-313063 Cr2859 Cr682 Cr531 Cr-1214 Cr-43.18
2023-12-312507 Cr2997 Cr-374 Cr-521 Cr-331 Cr-12.45
2023-09-303207 Cr3008 Cr17 Cr-124 Cr-64 Cr-2.90
2023-03-313374 Cr3025 Cr-344 Cr-491 Cr-403 Cr-15.18
2022-12-313464 Cr3103 Cr633 Cr471 Cr291 Cr9.66

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન2026-03-31
46.6%પ્રમોટર
પ્રમોટર46.6%
FII20.3%
DII19.3%
સાર્વજનિક53.4%
સરકાર0.0%
પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ
46.6%24-0646.6%24-0946.6%24-1246.6%25-0346.6%25-0946.6%25-1246.6%26-03

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખપ્રકારહેતુ
2025-10-03DividendInterim Dividend - Rs 2.50 Per Share
2025-09-15DividendDividend - Rs 2.50 Per Share
2024-09-13DividendDividend - Rs 2.50 Per Share
2023-09-18DividendDividend - Rs 2.50 Per Share
2022-09-12DividendAnnual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-08Dividend Annual General Meeting/Dividend - Rs 2.50 Per Share
2020-09-17Dividend Annual General Meeting/Dividend - Rs 2.50 Per Share
2019-09-19Dividend Annual General Meeting/Dividend - Rs 2 Per Share
2018-09-19Dividend Annual General Meeting/Dividend Rs 2 Per Share
2017-09-20Dividend Annual General Meeting/Dividend - Rs 2/- Per Share
2016-08-03Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2015-09-10Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-07-10DividendAnnual General Meeting / Dividend - Rs 2/- Per Share
2013-07-18DividendAnnual General Meeting / Dividend - Rs 2/- Per Share
2012-07-19DividendAnnual General Meeting / Dividend Rs 2 Per Share
2011-07-28DividendAnnual General Meeting And Dividend Re.0.40 Per Share
2010-09-16DividendAnnual General Meeting And Dividend Re.0.40 Per Share
2009-09-10OtherAgm/Div-Re.0.40 Per Share
2008-09-18OtherAnnual General Meeting
2007-11-07DividendInterim Dividend-70% Purpose Revised

કમાણી ટ્રાન્સક્રિપ્ટ

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Nov 2025NSE20K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Aug 2025NSE14K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
23 May 2025NSE18K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Feb 2025NSE18K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Feb 2024NSE20K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Nov 2023NSE24K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
21 Sept 2023NSE11K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
19 May 2023NSE22K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Feb 2023NSE20K chars
Read →
Further to our letter dated 03rd November, 2022 and pursuant to Regulation 30(6) read with Part A of...
18 Nov 2022NSE1K chars
Read →
Further to our communication dated November 11, 2022, attached is a copy of the presentation to be m...
17 Nov 2022NSE42K chars
Read →
Audio recording of Q2 of FY 2022-23 Earnings Call
14 Nov 2022NSE1K chars
Read →
Enclosed please find herewith the details of Earnings Call slated for Monday, November 14, 2022 at 9...
3 Nov 2022NSE2K chars
Read →
Further to our letter dated 01st August, 2022 and pursuant to Regulation 30(6) read with Part A of S...
17 Aug 2022NSE2K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Audio recording of Q1 of FY 2022-23...
12 Aug 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutiona...
3 Jun 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Audio recording of Q4 & FY22 Earnin...
30 May 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange regarding "Investor Presentation of the C...
12 Jan 2016NSE
Read →
Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of the Investor Presentation o...
14 Jan 2015NSE
Read →

ભાવ ઇતિહાસ

તારીખખૂલ્લઊંચનીચબંધવૉલ્યુમ
2026-05-06૨,૪૩૫.૦૦૨,૪૪૦.૦૦૨,૩૫૪.૯૦૨,૩૭૭.૬૦૧૧.૦૯L
2026-05-05૨,૩૮૪.૩૦૨,૪૩૦.૦૦૨,૩૬૦.૦૦૨,૪૧૭.૯૦૯.૧૮L
2026-05-04૨,૪૩૪.૩૦૨,૪૩૮.૮૦૨,૩૮૨.૬૦૨,૩૯૩.૭૦૪.૫૧L
2026-04-30૨,૪૦૦.૧૦૨,૪૫૫.૯૦૨,૩૮૫.૬૦૨,૪૦૬.૩૦૭.૯૩L
2026-04-29૨,૪૧૮.૭૦૨,૪૭૪.૦૦૨,૪૦૩.૭૦૨,૪૧૩.૯૦૬.૧૭L
2026-04-28૨,૩૨૮.૧૦૨,૪૨૭.૪૦૨,૩૨૭.૩૦૨,૪૦૩.૭૦૧૫.૩૮L
2026-04-27૨,૩૧૨.૦૦૨,૩૩૯.૯૦૨,૨૯૦.૯૦૨,૩૨૫.૧૦૪.૬૩L
2026-04-24૨,૩૫૧.૦૦૨,૩૭૨.૮૦૨,૨૮૩.૨૦૨,૨૯૯.૫૦૮.૩૮L
2026-04-23૨,૨૪૭.૯૦૨,૩૫૯.૪૦૨,૨૧૨.૧૦૨,૩૩૫.૦૦૧૭.૦૪L
2026-04-22૨,૨૩૩.૧૦૨,૨૪૭.૦૦૨,૨૦૪.૮૦૨,૨૪૦.૦૦૩.૨૩L
2026-04-21૨,૨૨૧.૯૦૨,૨૪૫.૦૦૨,૨૧૫.૨૦૨,૨૩૩.૧૦૨.૫૫L
2026-04-20૨,૨૪૯.૫૦૨,૨૫૦.૫૦૨,૨૧૦.૫૦૨,૨૩૦.૭૦૪.૦૮L
2026-04-17૨,૨૪૯.૫૦૨,૨૭૪.૯૦૨,૨૪૦.૯૦૨,૨૪૯.૫૦૩.૬૬L
2026-04-16૨,૨૬૭.૦૦૨,૨૭૩.૮૦૨,૨૨૮.૬૦૨,૨૪૯.૫૦૪.૩૪L
2026-04-15૨,૨૩૦.૯૦૨,૨૬૫.૦૦૨,૨૦૫.૦૦૨,૨૫૮.૪૦૬.૧૭L
2026-04-13૨,૧૫૩.૪૦૨,૨૦૫.૦૦૨,૧૧૫.૧૦૨,૧૯૩.૧૦૭.૨૪L
2026-04-10૨,૧૭૩.૯૦૨,૧૯૮.૯૦૨,૧૪૮.૯૦૨,૧૬૩.૨૦૬.૬૯L
2026-04-09૨,૧૭૩.૫૦૨,૧૮૬.૨૦૨,૧૪૨.૦૦૨,૧૬૯.૧૦૬.૧૩L
2026-04-08૨,૧૬૫.૦૦૨,૧૮૭.૦૦૨,૧૨૯.૬૦૨,૧૭૩.૫૦૫.૪૫L
2026-04-07૨,૧૦૦.૦૦૨,૧૩૮.૦૦૨,૦૬૮.૨૦૨,૧૧૪.૧૦૩.૮૮L
2026-04-02૨,૦૮૫.૦૦૨,૦૯૮.૪૦૧,૯૬૬.૫૦૨,૦૯૧.૮૦૯.૭૦L
2026-04-01૨,૧૮૦.૦૦૨,૨૩૮.૪૦૨,૦૮૫.૦૦૨,૧૦૧.૧૦૧૦.૧૨L
2026-03-27૨,૧૬૮.૫૦૨,૧૮૮.૪૦૨,૧૪૬.૬૦૨,૧૭૦.૫૦૭.૪૪L
2026-03-25૨,૧૨૦.૦૦૨,૧૭૯.૭૦૨,૧૦૨.૪૦૨,૧૬૮.૫૦૪.૪૭L
2026-03-24૨,૧૦૩.૦૦૨,૧૩૭.૧૦૨,૦૭૮.૩૦૨,૦૯૫.૭૦૫.૪૦L
2026-03-20૨,૧૧૪.૧૦૨,૧૯૦.૯૦૨,૧૧૦.૧૦૨,૧૮૦.૧૦૫.૯૭L
2026-03-19૨,૧૭૪.૦૦૨,૧૭૬.૬૦૨,૦૮૭.૪૦૨,૦૯૭.૫૦૪.૬૫L
2026-03-18૨,૧૪૫.૯૦૨,૨૩૭.૬૦૨,૧૪૩.૧૦૨,૧૮૬.૩૦૮.૮૩L
2026-03-17૨,૧૭૯.૯૦૨,૧૮૪.૭૦૨,૧૩૬.૦૦૨,૧૪૫.૯૦૭.૭૪L
2026-03-16૨,૧૭૨.૫૦૨,૨૧૪.૮૦૨,૧૪૫.૦૦૨,૧૭૫.૪૦૫.૨૯L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

ગ્લેનમાર્ક ફાર્માસ્યુટિકલ્સ લિમિટેડ, મુંબઈમાં મુખ્યમથક ધરાવતી ભારત સ્થિત ફાર્માસ્યુટિકલ કંપની, સક્રિય ફાર્માસ્યુટિકલ ઘટકો (APIs) અને ફોર્મ્યુલેશન સહિત, સ્થાનિક અને આંતરરાષ્ટ્રીય બજારોમાં સેવા પૂરી પાડતી જેનરિક અને વિશેષતા દવાઓની શ્રેણી, ડિઝાઇન, ઉત્પાદન અને માર્કેટિંગ કરે છે. મુખ્ય ઉત્પાદનોમાં કાર્ડિયોવેસ્ક્યુલર, સેન્ટ્રલ નર્વસ સિસ્ટમ ડિસઓર્ડર અને ઓન્કોલોજી માટે સારવારનો સમાવેશ થાય છે.

Advertisement
BOARD OF DIRECTORS
Anurag Mantri
Executive Director
DEPARTED
Anurag Mantri
Whole-time Director
Milind Sarwate
Independent Director
DEPARTED
Pradeep Kumar Sinha
Independent Director
Rajesh Desai
Independent Director
DEPARTED
Vijayalakshmi Rajaram Iyer
Independent Director